Effects of chronic Δ 9 -tetrahydrocannabinol treatment on Rho/Rho-kinase signalization pathway in mouse brain

Ahnert-Hilger, 2004, Differential effects of Rho GTPases on axonal and dendritic development in hippocampal neurones, J. Neurochem., 90, 9, 10.1111/j.1471-4159.2004.02475.x Ayman, 2003, Receptor-independent activation of Rho-kinase-mediated calcium sensitisation in smooth muscle, Br. J. Pharmacol., 139, 1532, 10.1038/sj.bjp.0705394 Cao, 2014, The potential therapeutic effects of THC on Alzheimer's disease, J. Alzheimer's Disease: JAD, 42, 973, 10.3233/JAD-140093 Charest, 2007, Big roles for small GTPases in the control of directed cell movement, Biochem. J., 401, 377, 10.1042/BJ20061432 Chen, 2007, RhoA regulates dendrite branching in hippocampal neurons by decreasing cypin protein levels, J. Neurosci.: Off. J. Soc. Neurosci., 27, 8378, 10.1523/JNEUROSCI.0872-07.2007 Franklin, 2013, Cannabinoid receptor agonists upregulate and enhance serotonin 2A (5-HT(2A)) receptor activity via ERK1/2 signaling, Synapse, 67, 145, 10.1002/syn.21626 Galve-Roperh, 2006, Endocannabinoids: a new family of lipid mediators involved in the regulation of neural cell development, Curr. Pharm. Des., 12, 2319, 10.2174/138161206777585139 Hall, 1998, Rho GTPases and the actin cytoskeleton, Science, 279, 509, 10.1126/science.279.5350.509 Hirvonen, 2012, Reversible and regionally selective downregulation of brain cannabinoid CB1 receptors in chronic daily cannabis smokers, Mol. Psychiatry, 17, 642, 10.1038/mp.2011.82 Julian, 2014, Rho-associated coiled-coil containing kinases (ROCK): structure, regulation, and functions, Small GTPases, 5, e29846, 10.4161/sgtp.29846 Kurihara, 2006, Effects of peripheral cannabinoid receptor ligands on motility and polarization in neutrophil-like HL60 cells and human neutrophils, J. Biol. Chem., 281, 12908, 10.1074/jbc.M510871200 Li, 2015, Activation of dopamine D1 receptors regulates dendritic morphogenesis through Rac1 and RhoA in prefrontal cortex neurons, Mol. Neurobiol., 51, 1024, 10.1007/s12035-014-8762-1 Maccarrone, 2003, The endocannabinoid system, anandamide and the regulation of mammalian cell apoptosis, Cell Death Differ., 10, 946, 10.1038/sj.cdd.4401284 Mechoulam, R., Spatz, M., Shohami, E., 2002. Endocannabinoids and Neuroprotection. Science's STKE: Signal Transduction Knowledge Environment, 2002, re5. Nagayama, 1999, Cannabinoids and neuroprotection in global and focal cerebral ischemia and in neuronal cultures, J. Neurosci.: Off. J. Soc. Neurosci., 19, 2987, 10.1523/JNEUROSCI.19-08-02987.1999 Piomelli, 2003, The molecular logic of endocannabinoid signalling, Nat. Rev. Neurosci., 4, 873, 10.1038/nrn1247 Quilter, 2012, Gene structure and expression of serotonin receptor HTR2C in hypothalamic samples from infanticidal and control sows, BMC Neurosci., 13, 37, 10.1186/1471-2202-13-37 Rao, 2006, Cannabinoid-mediated elevation of intracellular calcium: a structure-activity relationship, J. Pharmacol. Exper. Therapeut., 317, 820, 10.1124/jpet.105.100503 Tournier, 2016, Time-dependent effects of repeated THC treatment on dopamine D2/3 receptor-mediated signalling in midbrain and striatum, Behav. Brain Res., 311, 322, 10.1016/j.bbr.2016.05.045 Vogt, 2003, Receptor-dependent RhoA activation in G12/G13-deficient cells: genetic evidence for an involvement of Gq/G11, J. Biol. Chem., 278, 28743, 10.1074/jbc.M304570200